silence-therapeutics.com (SLN) - Company Sales Revenue

Corporate emblem and logo of Silence Therapeutics plc (SLN)

Silence Therapeutics is integrating ESG principles into RNA therapeutics, strictly adhering to bioethics and environmental sustainability. The technical state of the laboratories allows for the efficient scaling of drug synthesis. The company's current sales volume demonstrates revenue dynamics, where the indicator stands at 0.00, helping to avoid purchasing the asset at its peak. Meanwhile, production and clinical trials have been delegated to external contract partners.

SLN Silence Therapeutics Corp: Company Revenue in the range 06/21/2023 - 11/17/2026

Analytical breakdowns for Silence Therapeutics

- share price and consensus valuation forecast:
Summary company analysis:SLN (Silence Therapeutics plc)
Core merchandise of silence-therapeutics.com

Silence Therapeutics (SLN) sales reflect a net revenue stream without quarterly window dressing, allowing for the differentiation of speculative growth from fundamental business resilience. In the case of Silence Therapeutics (SLN), this trend is confirmed by the effective implementation of ESG standards in RNA therapeutics and the optimization of laboratory costs. Close monitoring of Silence Therapeutics (SLN) sales reveals the actual pace of monetization for bioethical innovations. This indicator serves as a measure of the issuer's operational viability, and investors should utilize it to assess the strategic preservation of capital.

Competing companies

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume TXG|Revenue and Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Sales|BioLife Solutions Inc (BLFS) - Company Total Revenue|wavelifesciences.com - Revenue and Sales Volume|Maze Therapeutics Corp (MAZE) - Company Sales|SION: Revenue and Sales Volume|Company Sales Volume PRME|Company Revenue Taysha Gene Therapies|Company Sales Volume QURE (uniQure)|Company Revenue MeiraGTx (MGTX)|REGENXBIO Corp - Company Sales Volume|Company Revenue Solid Biosciences SLDB|OCGN - Company Sales|pacb.com - Revenue and Sales Volume|Benitec (BNTC) - Company Sales|DSGN: Revenue and Sales Volume|RCKT - Company Gross Revenue|FDMT: Company Gross Revenue|Company Sales Volume LXEO (lexeotx.com)|Company Revenue Korro Bio Inc. (KRRO)|Company Total Sales EDIT|Company Revenue ProQR Therapeutics N.V. PRQR|Company Gross Revenue Codexis, Inc. (CDXS)|SGMO - Company Revenue|nautilus.bio - Company Total Sales|Metagenomi, Inc (MGX) - Company Revenue|Company Sales Volume DTIL|Company Revenue Generation Bio|Revenue and Sales Volume Boundless Bio Inc|Company Revenue Exicure Corp (XCUR)|Company Gross Revenue Imunon|Revenue and Sales Volume PHIO (phiopharma.com)|Company Total Sales Volume mustangbio.com|RNAZ - Company Revenue|Company Total Revenue Bionano Genomics|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales